The live rate of sarcoma, or cancer of the connective tissue, varies depending on the stage of sarcoma at diagnosis. As of 2020, the five-year survival rate for localized sarcoma (cancer that has not spread beyond the area of origin) is approximately 70%. The five-year survival rate for regional sarcoma (cancer that has spread to nearby lymph nodes or organs) is approximately 50%. The five-year survival rate for distant sarcoma (cancer that has spread to other parts of the body) is approximately 20%.
However, it is important to note that these survival rates are affected by a number of factors, including the type of sarcoma, the patient’s age, and the patient’s overall health. For example, certain types of sarcoma, such as Ewing’s sarcoma, tend to be more aggressive and have lower survival rates. Similarly, younger patients tend to have higher survival rates than older patients.
In addition, the live rate of sarcoma can also vary depending on the treatments available. For example, surgery, radiation, and chemotherapy can all be used to treat sarcoma, and the effectiveness of these treatments can affect the patient’s survival rate.
Overall, the live rate of sarcoma depends on several factors and can vary from patient to patient. It is important to discuss the specific prognosis with a qualified healthcare professional.